kynurenine has been researched along with Carcinoma, Renal Cell in 5 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Matched renal cell carcinoma (RCC) and normal kidney tissues were subject to proteomic profiling." | 1.56 | Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion. ( Banks, RE; Bhattarai, S; Brazma, A; Brown, J; Burns, J; Craven, RA; Dunn, KR; Feulner, L; Fukuwatari, T; Harris, A; Hornigold, N; Knowles, M; Lathrop, M; Maher, ER; Menon, M; Riazalhosseini, Y; Scelo, G; Selby, PJ; Sewell, H; Shires, M; Shreeve, R; Trainor, S; Vasudev, NS; Zougman, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H | 1 |
| Bullock, K | 1 |
| Gurjao, C | 1 |
| Braun, D | 1 |
| Shukla, SA | 1 |
| Bossé, D | 1 |
| Lalani, AA | 1 |
| Gopal, S | 1 |
| Jin, C | 1 |
| Horak, C | 1 |
| Wind-Rotolo, M | 1 |
| Signoretti, S | 1 |
| McDermott, DF | 1 |
| Freeman, GJ | 1 |
| Van Allen, EM | 1 |
| Schreiber, SL | 1 |
| Stephen Hodi, F | 1 |
| Sellers, WR | 1 |
| Garraway, LA | 1 |
| Clish, CB | 1 |
| Choueiri, TK | 1 |
| Giannakis, M | 1 |
| Hornigold, N | 1 |
| Dunn, KR | 1 |
| Craven, RA | 1 |
| Zougman, A | 1 |
| Trainor, S | 1 |
| Shreeve, R | 1 |
| Brown, J | 1 |
| Sewell, H | 1 |
| Shires, M | 1 |
| Knowles, M | 1 |
| Fukuwatari, T | 1 |
| Maher, ER | 1 |
| Burns, J | 1 |
| Bhattarai, S | 1 |
| Menon, M | 1 |
| Brazma, A | 1 |
| Scelo, G | 1 |
| Feulner, L | 1 |
| Riazalhosseini, Y | 1 |
| Lathrop, M | 1 |
| Harris, A | 1 |
| Selby, PJ | 1 |
| Banks, RE | 1 |
| Vasudev, NS | 1 |
| Sumitomo, M | 1 |
| Takahara, K | 1 |
| Zennami, K | 1 |
| Nagakawa, T | 1 |
| Maeda, Y | 1 |
| Shiogama, K | 1 |
| Yamamoto, Y | 1 |
| Muto, Y | 1 |
| Nukaya, T | 1 |
| Takenaka, M | 1 |
| Fukaya, K | 1 |
| Ichino, M | 1 |
| Sasaki, H | 1 |
| Saito, K | 1 |
| Shiroki, R | 1 |
| Lucarelli, G | 1 |
| Rutigliano, M | 1 |
| Ferro, M | 1 |
| Giglio, A | 1 |
| Intini, A | 1 |
| Triggiano, F | 1 |
| Palazzo, S | 1 |
| Gigante, M | 1 |
| Castellano, G | 1 |
| Ranieri, E | 1 |
| Buonerba, C | 1 |
| Terracciano, D | 1 |
| Sanguedolce, F | 1 |
| Napoli, A | 1 |
| Maiorano, E | 1 |
| Morelli, F | 1 |
| Ditonno, P | 1 |
| Battaglia, M | 1 |
| Van Gool, AR | 1 |
| Verkerk, R | 1 |
| Fekkes, D | 1 |
| Bannink, M | 1 |
| Sleijfer, S | 1 |
| Kruit, WH | 1 |
| van der Holt, B | 1 |
| Scharpé, S | 1 |
| Eggermont, AM | 1 |
| Stoter, G | 1 |
| Hengeveld, MW | 1 |
5 other studies available for kynurenine and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Metabolomic adaptations and correlates of survival to immune checkpoint blockade.
Topics: Adaptation, Physiological; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials as To | 2019 |
Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion.
Topics: 3-Hydroxyanthranilate 3,4-Dioxygenase; Carcinoma, Renal Cell; Cell Line, Tumor; Cytokines; Gene Expr | 2020 |
Tryptophan 2,3-dioxygenase in tumor cells is associated with resistance to immunotherapy in renal cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell | 2021 |
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Female; Humans; Kynurenine; Male; Middle Aged; Prognosis | 2017 |
Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status.
Topics: Adult; Aged; Brain; Carcinoma, Renal Cell; Depressive Disorder, Major; Dose-Response Relationship, D | 2008 |